USD 10.04
(-3.09%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -47.84 Million USD | 28.94% |
2022 | -67.32 Million USD | -391.68% |
2021 | -13.69 Million USD | -609.79% |
2020 | 2.68 Million USD | -13.83% |
2019 | 3.11 Million USD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q2 | -13.78 Million USD | 9.53% |
2024 Q1 | -15.23 Million USD | 22.11% |
2023 Q3 | -8.33 Million USD | 23.55% |
2023 FY | -47.84 Million USD | 28.94% |
2023 Q4 | -19.55 Million USD | -134.75% |
2023 Q2 | -10.89 Million USD | -20.39% |
2023 Q1 | -9.05 Million USD | 76.65% |
2022 Q1 | -9.23 Million USD | -49.6% |
2022 Q4 | -38.76 Million USD | -298.63% |
2022 FY | -67.32 Million USD | -391.68% |
2022 Q3 | -9.72 Million USD | -1.26% |
2022 Q2 | -9.6 Million USD | -3.97% |
2021 FY | -13.69 Million USD | -609.79% |
2021 Q4 | -6.17 Million USD | -20.89% |
2021 Q3 | -5.1 Million USD | -171.07% |
2021 Q2 | -1.88 Million USD | -257.5% |
2021 Q1 | -527 Thousand USD | -114.3% |
2020 FY | 2.68 Million USD | -13.83% |
2020 Q4 | 3.68 Million USD | 6.07% |
2020 Q3 | 3.47 Million USD | 255.31% |
2020 Q2 | -2.23 Million USD | 0.0% |
2020 Q1 | -2.23 Million USD | 0.0% |
2019 FY | 3.11 Million USD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Abbott Laboratories | 5.72 Billion USD | 100.836% |
Allurion Technologies Inc. | -82.3 Million USD | 41.873% |
Artivion, Inc. | -30.69 Million USD | -55.885% |
Avanos Medical, Inc. | -61.8 Million USD | 22.587% |
Butterfly Network, Inc. | -133.69 Million USD | 64.218% |
Butterfly Network, Inc. | -133.69 Million USD | 64.218% |
Bio-Rad Laboratories, Inc. | -637.32 Million USD | 92.493% |
Boston Scientific Corporation | 1.59 Billion USD | 103.003% |
Perspective Therapeutics, Inc. | -14.67 Million USD | -226.115% |
CONMED Corporation | 64.45 Million USD | 174.219% |
Edwards Lifesciences Corporation | 1.4 Billion USD | 103.411% |
Glaukos Corporation | -134.66 Million USD | 64.473% |
Globus Medical, Inc. | 122.87 Million USD | 138.935% |
Inspire Medical Systems, Inc. | -21.15 Million USD | -126.167% |
Integer Holdings Corporation | 90.65 Million USD | 152.776% |
Medtronic plc | 3.67 Billion USD | 101.301% |
Nevro Corp. | -92.21 Million USD | 48.119% |
Owlet, Inc. | -32.9 Million USD | -45.409% |
Penumbra, Inc. | 90.95 Million USD | 152.599% |
Vicarious Surgical Inc. | -71.07 Million USD | 32.686% |
Smith & Nephew plc | 263 Million USD | 118.19% |
Sonendo, Inc. | -60.91 Million USD | 21.468% |
STERIS plc | 378.23 Million USD | 112.648% |
Stryker Corporation | 3.16 Billion USD | 101.512% |
Vapotherm, Inc. | -58.19 Million USD | 17.789% |
Zimmer Biomet Holdings, Inc. | 1.02 Billion USD | 104.672% |